Annual CFF
-$122.40 M
-$145.01 M-641.20%
30 June 2024
Summary:
Bio-Techne annual cash flow from financing activities is currently -$122.40 million, with the most recent change of -$145.01 million (-641.20%) on 30 June 2024. During the last 3 years, it has fallen by -$59.85 million (-95.68%). TECH annual CFF is now -164.72% below its all-time high of $189.11 million, reached on 30 June 2017.TECH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$11.57 M
+$48.52 M+80.75%
30 September 2024
Summary:
Bio-Techne quarterly cash flow from financing activities is currently -$11.57 million, with the most recent change of +$48.52 million (+80.75%) on 30 September 2024. Over the past year, it has dropped by -$83.08 million (-116.18%). TECH quarterly CFF is now -104.78% below its all-time high of $242.16 million, reached on 30 September 2016.TECH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$205.48 M
-$83.08 M-67.88%
30 September 2024
Summary:
Bio-Techne TTM cash flow from financing activities is currently -$205.48 million, with the most recent change of -$83.08 million (-67.88%) on 30 September 2024. Over the past year, it has dropped by -$331.42 million (-263.17%). TECH TTM CFF is now -208.66% below its all-time high of $189.11 million, reached on 30 June 2017.TECH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TECH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -641.2% | -116.2% | -263.2% |
| 3 y3 years | -95.7% | +70.8% | -205.3% |
| 5 y5 years | -191.1% | +52.3% | -82.8% |
TECH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -641.2% | +49.6% | -107.7% | +86.2% | -263.2% | +19.0% |
| 5 y | 5 years | -191.1% | +49.6% | -107.7% | +88.1% | -263.2% | +19.0% |
| alltime | all time | -164.7% | +49.6% | -104.8% | +88.8% | -208.7% | +19.0% |
Bio-Techne Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.57 M(-80.7%) | -$205.48 M(+67.9%) |
| June 2024 | -$122.40 M(-641.2%) | -$60.09 M(+14.7%) | -$122.40 M(+41.5%) |
| Mar 2024 | - | -$52.42 M(-35.6%) | -$86.53 M(-174.1%) |
| Dec 2023 | - | -$81.40 M(-213.8%) | $116.73 M(-7.3%) |
| Sept 2023 | - | $71.51 M(-395.2%) | $125.93 M(+456.8%) |
| June 2023 | $22.62 M(-109.3%) | -$24.22 M(-116.1%) | $22.62 M(-219.7%) |
| Mar 2023 | - | $150.84 M(-308.9%) | -$18.89 M(-92.6%) |
| Dec 2022 | - | -$72.19 M(+127.0%) | -$253.79 M(+8.0%) |
| Sept 2022 | - | -$31.81 M(-51.6%) | -$234.97 M(-3.2%) |
| June 2022 | -$242.85 M(+288.2%) | -$65.73 M(-21.8%) | -$242.85 M(+308.6%) |
| Mar 2022 | - | -$84.06 M(+57.5%) | -$59.44 M(+94.2%) |
| Dec 2021 | - | -$53.38 M(+34.5%) | -$30.60 M(-54.5%) |
| Sept 2021 | - | -$39.68 M(-133.7%) | -$67.30 M(+7.6%) |
| June 2021 | -$62.55 M(-66.0%) | $117.69 M(-313.1%) | -$62.55 M(-72.2%) |
| Mar 2021 | - | -$55.23 M(-38.7%) | -$224.96 M(+20.0%) |
| Dec 2020 | - | -$90.08 M(+157.9%) | -$187.52 M(-3.6%) |
| Sept 2020 | - | -$34.93 M(-21.9%) | -$194.47 M(+5.8%) |
| June 2020 | -$183.80 M(-236.8%) | -$44.72 M(+151.4%) | -$183.80 M(+15.6%) |
| Mar 2020 | - | -$17.79 M(-81.7%) | -$158.98 M(-5.5%) |
| Dec 2019 | - | -$97.03 M(+299.8%) | -$168.24 M(+49.7%) |
| Sept 2019 | - | -$24.27 M(+22.0%) | -$112.42 M(-183.7%) |
| June 2019 | $134.38 M(-235.5%) | -$19.90 M(-26.4%) | $134.38 M(+46.9%) |
| Mar 2019 | - | -$27.04 M(-34.4%) | $91.45 M(-22.2%) |
| Dec 2018 | - | -$41.21 M(-118.5%) | $117.54 M(-32.6%) |
| Sept 2018 | - | $222.53 M(-454.2%) | $174.30 M(-275.7%) |
| June 2018 | -$99.19 M(-152.4%) | -$62.83 M(+6500.0%) | -$99.19 M(+87.1%) |
| Mar 2018 | - | -$952.00 K(-106.1%) | -$53.00 M(-30.8%) |
| Dec 2017 | - | $15.55 M(-130.5%) | -$76.57 M(-26.4%) |
| Sept 2017 | - | -$50.95 M(+206.1%) | -$104.00 M(-155.0%) |
| June 2017 | $189.11 M(-909.2%) | -$16.64 M(-32.1%) | $189.11 M(+9.0%) |
| Mar 2017 | - | -$24.52 M(+106.3%) | $173.42 M(-2.8%) |
| Dec 2016 | - | -$11.88 M(-104.9%) | $178.41 M(+0.8%) |
| Sept 2016 | - | $242.16 M(-848.9%) | $176.93 M(-857.1%) |
| June 2016 | -$23.37 M(-174.7%) | -$32.33 M(+65.5%) | -$23.37 M(-69.5%) |
| Mar 2016 | - | -$19.54 M(+46.2%) | -$76.71 M(+12.5%) |
| Dec 2015 | - | -$13.37 M(-131.9%) | -$68.18 M(+132.5%) |
| Sept 2015 | - | $41.87 M(-148.9%) | -$29.33 M(-193.8%) |
| June 2015 | $31.27 M(-185.0%) | -$85.68 M(+678.9%) | $31.27 M(-71.3%) |
| Mar 2015 | - | -$11.00 M(-143.2%) | $108.94 M(-1.0%) |
| Dec 2014 | - | $25.48 M(-75.1%) | $110.03 M(+45.6%) |
| Sept 2014 | - | $102.47 M(-1379.4%) | $75.57 M(-305.3%) |
| June 2014 | -$36.81 M(-17.6%) | -$8.01 M(-19.2%) | -$36.81 M(-11.1%) |
| Mar 2014 | - | -$9.91 M(+10.3%) | -$41.38 M(-2.7%) |
| Dec 2013 | - | -$8.98 M(-9.3%) | -$42.52 M(-3.0%) |
| Sept 2013 | - | -$9.90 M(-21.3%) | -$43.83 M(-1.9%) |
| June 2013 | -$44.68 M(-30.9%) | -$12.58 M(+13.9%) | -$44.68 M(+0.3%) |
| Mar 2013 | - | -$11.05 M(+7.3%) | -$44.54 M(-4.6%) |
| Dec 2012 | - | -$10.30 M(-4.2%) | -$46.69 M(-13.3%) |
| Sept 2012 | - | -$10.75 M(-13.6%) | -$53.82 M(-16.7%) |
| June 2012 | -$64.63 M(+78.1%) | -$12.45 M(-5.7%) | -$64.63 M(+7.0%) |
| Mar 2012 | - | -$13.20 M(-24.3%) | -$60.42 M(+5.6%) |
| Dec 2011 | - | -$17.43 M(-19.2%) | -$57.24 M(+22.0%) |
| Sept 2011 | - | -$21.56 M(+161.6%) | -$46.93 M(+29.3%) |
| June 2011 | -$36.29 M(-28.2%) | -$8.24 M(-17.7%) | -$36.29 M(-29.0%) |
| Mar 2011 | - | -$10.02 M(+40.7%) | -$51.08 M(+2.9%) |
| Dec 2010 | - | -$7.12 M(-34.8%) | -$49.63 M(-3.7%) |
| Sept 2010 | - | -$10.91 M(-52.6%) | -$51.54 M(+2.0%) |
| June 2010 | -$50.51 M(-57.7%) | -$23.03 M(+168.8%) | -$50.51 M(+30.6%) |
| Mar 2010 | - | -$8.57 M(-5.2%) | -$38.68 M(-22.3%) |
| Dec 2009 | - | -$9.03 M(-8.6%) | -$49.79 M(-56.9%) |
| Sept 2009 | - | -$9.89 M(-11.7%) | -$115.61 M(-3.2%) |
| June 2009 | -$119.44 M(+111.1%) | -$11.20 M(-43.1%) | -$119.44 M(+0.7%) |
| Mar 2009 | - | -$19.67 M(-73.7%) | -$118.58 M(-6.7%) |
| Dec 2008 | - | -$74.85 M(+445.6%) | -$127.05 M(+77.8%) |
| Sept 2008 | - | -$13.72 M(+32.8%) | -$71.46 M(+26.3%) |
| June 2008 | -$56.59 M(+397.5%) | -$10.33 M(-63.3%) | -$56.59 M(+25.9%) |
| Mar 2008 | - | -$28.15 M(+46.1%) | -$44.96 M(+190.4%) |
| Dec 2007 | - | -$19.27 M(-1771.2%) | -$15.48 M(+74.4%) |
| Sept 2007 | - | $1.15 M(-11.7%) | -$8.88 M(-22.0%) |
| June 2007 | -$11.38 M | $1.31 M(-1.8%) | -$11.38 M(-10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $1.33 M(-110.5%) | -$12.76 M(+316.4%) |
| Dec 2006 | - | -$12.67 M(+842.5%) | -$3.06 M(-80.8%) |
| Sept 2006 | - | -$1.34 M(+1716.2%) | -$15.92 M(+100.9%) |
| June 2006 | -$7.92 M(-91.8%) | -$74.00 K(-100.7%) | -$7.92 M(+158.0%) |
| Mar 2006 | - | $11.02 M(-143.2%) | -$3.07 M(-97.4%) |
| Dec 2005 | - | -$25.52 M(-483.8%) | -$117.78 M(+29.6%) |
| Sept 2005 | - | $6.65 M(+39.2%) | -$90.85 M(-6.5%) |
| June 2005 | -$97.16 M(-3498.5%) | $4.78 M(-104.6%) | -$97.16 M(-4.0%) |
| Mar 2005 | - | -$103.69 M(-7474.5%) | -$101.17 M(-2658.2%) |
| Dec 2004 | - | $1.41 M(+316.0%) | $3.96 M(+58.5%) |
| Sept 2004 | - | $338.00 K(-55.9%) | $2.50 M(-12.7%) |
| June 2004 | $2.86 M(-112.9%) | $766.00 K(-47.0%) | $2.86 M(-703.0%) |
| Mar 2004 | - | $1.45 M(-2826.4%) | -$474.10 K(-97.2%) |
| Dec 2003 | - | -$53.00 K(-107.6%) | -$16.72 M(+8.1%) |
| Sept 2003 | - | $701.00 K(-127.3%) | -$15.47 M(-30.3%) |
| June 2003 | -$22.18 M(+1608.8%) | -$2.57 M(-82.7%) | -$22.18 M(+10.4%) |
| Mar 2003 | - | -$14.80 M(-1336.6%) | -$20.10 M(+275.3%) |
| Dec 2002 | - | $1.20 M(-119.9%) | -$5.35 M(-19.2%) |
| Sept 2002 | - | -$6.01 M(+1148.4%) | -$6.63 M(+410.7%) |
| June 2002 | -$1.30 M(+10.7%) | -$481.80 K(+782.4%) | -$1.30 M(+33.9%) |
| Mar 2002 | - | -$54.60 K(-31.2%) | -$969.40 K(-48.0%) |
| Dec 2001 | - | -$79.40 K(-88.4%) | -$1.87 M(-11.9%) |
| Sept 2001 | - | -$682.40 K(+346.0%) | -$2.12 M(+80.4%) |
| June 2001 | -$1.17 M(-104.5%) | -$153.00 K(-83.9%) | -$1.17 M(-176.9%) |
| Mar 2001 | - | -$950.40 K(+187.0%) | $1.53 M(-71.0%) |
| Dec 2000 | - | -$331.10 K(-226.7%) | $5.26 M(-10.7%) |
| Sept 2000 | - | $261.30 K(-89.7%) | $5.89 M(-77.5%) |
| June 2000 | $26.23 M(-1036.8%) | $2.55 M(-8.6%) | $26.23 M(+19.3%) |
| Mar 2000 | - | $2.78 M(+828.1%) | $21.98 M(+13.3%) |
| Dec 1999 | - | $300.00 K(-98.5%) | $19.40 M(+4.3%) |
| Sept 1999 | - | $20.60 M(-1311.8%) | $18.60 M(-764.3%) |
| June 1999 | -$2.80 M(-566.7%) | -$1.70 M(-950.0%) | -$2.80 M(+211.1%) |
| Mar 1999 | - | $200.00 K(-140.0%) | -$900.00 K(+12.5%) |
| Dec 1998 | - | -$500.00 K(-37.5%) | -$800.00 K(-900.0%) |
| Sept 1998 | - | -$800.00 K(-500.0%) | $100.00 K(-83.3%) |
| June 1998 | $600.00 K(-123.1%) | $200.00 K(-33.3%) | $600.00 K(-14.3%) |
| Mar 1998 | - | $300.00 K(-25.0%) | $700.00 K(-200.0%) |
| Dec 1997 | - | $400.00 K(-233.3%) | -$700.00 K(-50.0%) |
| Sept 1997 | - | -$300.00 K(-200.0%) | -$1.40 M(-46.2%) |
| June 1997 | -$2.60 M(+2500.0%) | $300.00 K(-127.3%) | -$2.60 M(-3.7%) |
| Mar 1997 | - | -$1.10 M(+266.7%) | -$2.70 M(+80.0%) |
| Dec 1996 | - | -$300.00 K(-80.0%) | -$1.50 M(+7.1%) |
| Sept 1996 | - | -$1.50 M(-850.0%) | -$1.40 M(+1300.0%) |
| June 1996 | -$100.00 K(-75.0%) | $200.00 K(+100.0%) | -$100.00 K(-87.5%) |
| Mar 1996 | - | $100.00 K(-150.0%) | -$800.00 K(-11.1%) |
| Dec 1995 | - | -$200.00 K(0.0%) | -$900.00 K(+50.0%) |
| Sept 1995 | - | -$200.00 K(-60.0%) | -$600.00 K(+50.0%) |
| June 1995 | -$400.00 K(<-9900.0%) | -$500.00 K(<-9900.0%) | -$400.00 K(-500.0%) |
| Mar 1995 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| Dec 1994 | - | $100.00 K(>+9900.0%) | $100.00 K(>+9900.0%) |
| Sept 1994 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1994 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1994 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1993 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 1993 | - | $0.00(0.0%) | $100.00 K(0.0%) |
| June 1993 | $100.00 K(-125.0%) | $0.00(0.0%) | $100.00 K(-150.0%) |
| Mar 1993 | - | $0.00(-100.0%) | -$200.00 K(-33.3%) |
| Dec 1992 | - | $100.00 K(>+9900.0%) | -$300.00 K(0.0%) |
| Sept 1992 | - | $0.00(-100.0%) | -$300.00 K(-25.0%) |
| June 1992 | -$400.00 K(+100.0%) | -$300.00 K(+200.0%) | -$400.00 K(0.0%) |
| Mar 1992 | - | -$100.00 K(-200.0%) | -$400.00 K(+100.0%) |
| Dec 1991 | - | $100.00 K(-200.0%) | -$200.00 K(-33.3%) |
| Sept 1991 | - | -$100.00 K(-66.7%) | -$300.00 K(+50.0%) |
| June 1991 | -$200.00 K(-50.0%) | -$300.00 K(-400.0%) | -$200.00 K(0.0%) |
| Mar 1991 | - | $100.00 K(>+9900.0%) | -$200.00 K(-60.0%) |
| Dec 1990 | - | $0.00(0.0%) | -$500.00 K(0.0%) |
| Sept 1990 | - | $0.00(-100.0%) | -$500.00 K(+25.0%) |
| June 1990 | -$400.00 K | -$300.00 K(+50.0%) | -$400.00 K(+300.0%) |
| Mar 1990 | - | -$200.00 K(<-9900.0%) | -$100.00 K(-200.0%) |
| Dec 1989 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| Sept 1989 | - | $100.00 K | $100.00 K |
FAQ
- What is Bio-Techne annual cash flow from financing activities?
- What is the all time high annual CFF for Bio-Techne?
- What is Bio-Techne annual CFF year-on-year change?
- What is Bio-Techne quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bio-Techne?
- What is Bio-Techne quarterly CFF year-on-year change?
- What is Bio-Techne TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bio-Techne?
- What is Bio-Techne TTM CFF year-on-year change?
What is Bio-Techne annual cash flow from financing activities?
The current annual CFF of TECH is -$122.40 M
What is the all time high annual CFF for Bio-Techne?
Bio-Techne all-time high annual cash flow from financing activities is $189.11 M
What is Bio-Techne annual CFF year-on-year change?
Over the past year, TECH annual cash flow from financing activities has changed by -$145.01 M (-641.20%)
What is Bio-Techne quarterly cash flow from financing activities?
The current quarterly CFF of TECH is -$11.57 M
What is the all time high quarterly CFF for Bio-Techne?
Bio-Techne all-time high quarterly cash flow from financing activities is $242.16 M
What is Bio-Techne quarterly CFF year-on-year change?
Over the past year, TECH quarterly cash flow from financing activities has changed by -$83.08 M (-116.18%)
What is Bio-Techne TTM cash flow from financing activities?
The current TTM CFF of TECH is -$205.48 M
What is the all time high TTM CFF for Bio-Techne?
Bio-Techne all-time high TTM cash flow from financing activities is $189.11 M
What is Bio-Techne TTM CFF year-on-year change?
Over the past year, TECH TTM cash flow from financing activities has changed by -$331.42 M (-263.17%)